소아 바이러스성 급성장관감염증의 혈위 첩부 요법에 대한 최근 임상연구 동향

Abstract

Objectives This study aimed to analyze recent clinical research trends in acupoint application therapy for pediatric viral acute gastroenteritis based on randomized controlled trials (RCTs) and to evaluate its efficacy and safety. Methods Nine RCTs published between January 2020 and October 2025 were identified using PubMed and the China National Knowledge Infrastructure (CNKI). The study design, herbal composition, selected acupoints, evaluation indicators, and key outcomes were systematically reviewed. Results The most frequently used acupoint was Shenque (CV8), and the main herbs used were Atractylodis Rhizoma, Coptidis Rhizoma, and Evodiae Fructus. In most studies, the total efficacy rate of the treatment group was significantly higher than that of the control group (p < 0.05). Symptom relief, including improvements in diarrhea and vomiting and reductions in symptom scores, were consistently reported. Adverse reactions were either absent or mild, with no significant differences between groups. Conclusions Acupoint application therapy has demonstrated significant efficacy in improving symptoms and treatment outcomes in pediatric viral acute gastroenteritis, with good safety profiles. It may serve as a promising complementary and alternative therapy. However, large-scale clinical trials are warranted to further substantiate its efficacy and safety.